Cardiomyocyte apoptosis is associated with increased wall stress in chronic failing left ventricle

L Jiang1, Y Huang, S Hunyor

  • 1Department of Cardiology, Cardiac Technology Centre, Royal North Shore Hospital, St. Leonards, NSW, Australia. lelej@physiol.usyd.edu.au

European Heart Journal
|April 26, 2003
PubMed

Insights

In chronic heart failure (HF), cardiomyocyte apoptosis is linked to increased cardiac wall stress. This stress may activate the Fas/FasL and caspase-8 pathway in heart cells.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pathophysiology

Background:

  • Chronic heart failure (HF) is a complex condition with significant cardiomyocyte loss.
  • The mechanisms driving cardiomyocyte apoptosis in HF are not fully understood.
  • Elevated cardiac wall stress is a hallmark of HF and may contribute to cell death.

Purpose of the Study:

  • To investigate cardiomyocyte apoptosis in a sheep model of chronic heart failure (HF).
  • To explore the potential association between elevated cardiac wall stress and cardiomyocyte apoptosis.
  • To identify key molecular pathways involved in this process.

Main Methods:

  • A sheep model of chronic HF was established using sequential coronary microembolization.
  • Western blotting was used to assess the expression of apoptosis-related proteins (Fas, FasL, caspase-8, p20).
  • TUNEL assays quantified apoptotic cardiomyocytes, and hemodynamic analysis measured left ventricular (LV) wall stress.

Main Results:

  • HF sheep exhibited increased expression of Fas, FasL, and caspase-8, indicating cardiomyocyte apoptosis.
  • Apoptotic cardiomyocytes constituted 0.3% of the total, confirmed by TUNEL assays.
  • Increased LV wall stress, correlated with Fas/FasL expression, was observed in dilated ventricles.

Conclusions:

  • Cardiomyocyte apoptosis is present in chronic HF and is associated with increased cardiac wall stress.
  • Elevated wall stress may initiate apoptosis via the Fas/FasL and caspase-8 pathway at intercalated discs.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...